Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Anavex Life Sciences Corp (AVXL)

Add AVXL Price Alert      Hide Sticky   Hide Intro
Moderator: blanka, TheHound, 123tom, kevindenver, TomP1, Rubyred77
Search This Board: 
Last Post: 6/25/2017 1:47:34 AM - Followers: 701 - Board type: Free - Posts Today: 1

Anavex Life Sciences Corp (AVXL)

Company website:
Company Address:
51 West 52nd Street, 7th floor
New York, NY
10019 USA

CIK:  0001314052
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s, CNS diseases and various types of cancer, which have significant unmet medical needs.
ANAVEX 2-73, the Company’s orally available drug candidate developed to treat Alzheimer’s through potential disease modification, has undergone an initial Phase 1 human clinical trial and was well tolerated in doses up to 55mg.  Results from pre-clinical studies indicate that ANAVEX 2-73 demonstrates anti-amnesic and neuroprotective properties.
A highly encouraging synergistic effect has also been observed between ANAVEX 2-73 and donepezil (Aricept®).  The combined therapeutics, referred to as “ANAVEX PLUS,” produced up to 80% greater reversal of memory loss in Alzheimer’s disease models versus when the drugs were used individually.
ANAVEX PLUS is believed to be a compelling commercial opportunity.  The clinical trial risk is lower because donepezil (Aricept®) is already on the market, with global sales of $4-billion annually.  Donepezil (Aricept®) is now generic and a patent application has been filed for ANAVEX PLUS which, if granted, would provide protection until 2033.

Patent Info:

Clinical Trials:
Recent News:
Company News Releases:
Share Structure:  See SEC filings
Investor Relations:

Marketing Details:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AVXL News: Pharmaceutical Leaders Pave the Way to New Alzheimer’s Treatments 06/15/2017 07:00:00 AM
AVXL News: Notice of Effectiveness (effect) 06/13/2017 06:03:09 AM
AVXL News: Anavex Life Sciences to Present at Jefferies 2017 Global Healthcare Conference 06/05/2017 07:00:00 AM
AVXL News: Securities Registration Statement (simplified Form) (s-3) 05/26/2017 04:32:21 PM
AVXL News: Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders Including Angelman Syndrome: Data Prese... 05/22/2017 07:00:00 AM
#108606  Sticky Note Lots of negativity on the board today. sliceanddice59 06/15/17 01:27:12 AM
#103034  Sticky Note To answer your good questions. falconer66a 04/26/17 10:18:09 AM
#94047  Sticky Note Found a nice A-273 profile overview. Rubyred77 03/02/17 02:06:17 PM
#109579   Blu, Aducanumab and several other AZ drug Talon38 06/25/17 01:47:34 AM
#109578   I suspect these similar age related diseases have blu_1 06/24/17 11:29:30 PM
#109577   Requested Dosing Extension falconer66a 06/24/17 10:45:47 PM
#109576   Bingo...... I believe there is a common pathophysiological process dadofmarcmax 06/24/17 10:34:10 PM
#109575   This was linked to the YouTube on dissection XenaLives 06/24/17 09:43:19 PM
#109574   Couple months old, but still like to read whippinsaw 06/24/17 09:34:35 PM
#109573   Yep, raja. Like a very complicated JIGSAW PUZZLE. Batermere 06/24/17 09:27:33 PM
#109572   I am not a expert in any medical raja48185 06/24/17 08:52:00 PM
#109571 jta1980 06/24/17 07:46:20 PM
#109570   But you said "The problem is BP wants to Amatuer17 06/24/17 06:50:11 PM
#109569   Post of the month. A_Good_Day_2 06/24/17 05:35:51 PM
#109568   There is no problem McMagyar 06/24/17 04:34:33 PM
#109567   The problem is Dr M has not shown Amatuer17 06/24/17 04:17:10 PM
#109566   Tic tock...tic tock... A_Good_Day_2 06/24/17 03:29:13 PM
#109565   No more than when stocks are added or Kentucky123 06/24/17 03:28:34 PM
#109564   That will be done by the Aussie healthcare XenaLives 06/24/17 03:10:36 PM
#109563   Would Russell rebalancing be a motive for price control? XenaLives 06/24/17 03:09:20 PM
#109562   This is horrible... XenaLives 06/24/17 03:08:15 PM
#109561   Yes, and I wasn't either, I got what frrol 06/24/17 03:05:15 PM
#109560   Go ahead Treden.. drop the Mic! McMagyar 06/24/17 02:57:58 PM
#109559   Bam! McMagyar 06/24/17 02:51:12 PM
#109558   Mc I completely agree. As we await these tredenwater2 06/24/17 02:40:46 PM
#109557   It's why our Part B trials are a McMagyar 06/24/17 02:06:15 PM
#109556   There are other drugs that show curative properties McMagyar 06/24/17 11:52:55 AM
#109555   I am so excited that I may need ExtremelyBullishZig 06/24/17 11:44:39 AM
#109554   Believers: How can we not be EXCITED with bennyboy1 06/24/17 11:37:23 AM
#109553   I wasn't referencing 2-73 when saying that there ExtremelyBullishZig 06/24/17 11:27:28 AM
#109552   Agreed! The 2 year extension helps to tease dadofmarcmax 06/24/17 11:08:03 AM
#109551   Yes cognitive improvement is often transitory. It's shown frrol 06/24/17 10:48:14 AM
#109550   The closing and AH activity was due to attilathehunt 06/24/17 10:47:04 AM
#109549   By definition. That's what drives the induction fallacy frrol 06/24/17 10:33:13 AM
#109546   An interesting statistic. "A report released Tuesday by the F1ash 06/24/17 09:53:04 AM
#109545   Penny, you have it exactly right IMO. nidan7500 06/24/17 09:43:30 AM
#109544   Hence why I start AD patients on lamotrigine dadofmarcmax 06/24/17 09:40:15 AM
#109543   FYI raja48185 06/24/17 09:04:55 AM
#109542   Basically, all patent apps have been abandoned or ExtremelyBullishZig 06/24/17 08:56:01 AM
#109541   I think so, Dr. Missling is doing a Penny Double 06/24/17 08:54:11 AM
#109540   There may not be a magic one, but ExtremelyBullishZig 06/24/17 08:52:08 AM
#109539   Biotech investment experience prepares you for the reality frrol 06/24/17 08:47:32 AM
#109538   Patent application excerpts: falconer66a 06/24/17 08:46:45 AM
#109537   Yes a prepared biotech investor expects nothing of frrol 06/24/17 08:45:00 AM
#109536   Yes. There is no magic bean for advanced frrol 06/24/17 08:43:10 AM
#109535   Penny..thx, Could this explain some of our VERY quiet time???? nidan7500 06/24/17 08:34:11 AM
#109534   sokol...excellent catch, thanks for noting. We know there nidan7500 06/24/17 08:21:56 AM
#109533   Anavex recommendation from Zack's------not sure if this has plexrec 06/24/17 07:53:20 AM
#109532 your continuing stellar confidence ! Yes,we do plexrec 06/24/17 07:22:33 AM
#109531   Probably going to have to stop Alzheimer's early F1ash 06/24/17 03:32:10 AM
#109530   Not new. Filed in 2013. Final rejection notice neiu 06/24/17 12:57:28 AM
#109529   Since I had no idea what "Patent Application XenaLives 06/24/17 12:55:51 AM
#109528   New patent application for Anavex georgejjl 06/24/17 12:09:03 AM